Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xi'an Reyphon Pharmaceutical is a comprehensive pharmaceutical enterprise located in Xi'an, China, dedicated to the R&D, production, and sales of chemical drugs. The company operates GMP-certified manufacturing lines for various formulations, including tablets, capsules, and granules, as well as Active Pharmaceutical Ingredients (APIs). Its core therapeutic focus includes cardiovascular diseases, respiratory infections, and digestive system disorders. Reyphon is recognized for its production of widely used generics such as amlodipine and azithromycin, serving both the Chinese healthcare system and global export markets. The company also provides contract manufacturing services for international partners seeking high-quality chemical synthesis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xian Reyphon Pharmaceutical.